Progesterone administration route in gonadotropin-releasing hormone antagonist cycles.
Bahceci
Mustafa
M
Ulug
Ulun
U
D000282:Administration, Intravaginal; D000328:Adult; D002986:Clinical Trials as Topic; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors*; D006727:Hormone Antagonists / Q000008:administration & dosage*; D006801:Humans; D007246:Infertility / Q000188:drug therapy; D007273:Injections, Intramuscular; D008297:Male; D011247:Pregnancy; D018873:Pregnancy Rate; D011374:Progesterone / Q000008:administration & dosage*; D020554:Sperm Injections, Intracytoplasmic
D005300:Fertility Agents, Female; D006727:Hormone Antagonists; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; C062876:cetrorelix